2013
DOI: 10.1124/dmd.112.048025
|View full text |Cite
|
Sign up to set email alerts
|

Identification of the Active Components in Shenmai Injection that Differentially Affect Cyp3a4-Mediated 1′-Hydroxylation and 4-Hydroxylation of Midazolam

Abstract: Shenmai injection (SMI) is a popular herbal preparation that is widely used for the treatment of atherosclerotic coronary heart disease and viral myocarditis. In our previous study, SMI was shown to differentially affect CYP3A4-mediated 19-hydroxylation and 4-hydroxylation of midazolam (MDZ). The present study was conducted to identify the active components in SMI responsible for the differential effects on MDZ metabolism, using in vitro incubation systems (rat and human liver microsomes and a recombinant CYP3… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
9
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 15 publications
(9 citation statements)
references
References 26 publications
0
9
0
Order By: Relevance
“…dmd.aspetjournals.org modulators could exert different effects on each metabolite formation (Xia et al, 2009;Dong et al, 2011). As reported, erlotinib and panaxytriol, an active component in Shenmai injection (Zeng et al, 2013), both showed significant activation on MDZ 19-hydroxylation, whereas the activation but not inhibition made it difficult for the in vivo extrapolation. Moreover, either glucuronidation of hydroxylmidazolam or direct glucuronidation of MDZ occurs in vitro and in vivo (Klieber et al, 2008;Hyland et al, 2009;Seo et al, 2010).…”
Section: Discussionmentioning
confidence: 83%
“…dmd.aspetjournals.org modulators could exert different effects on each metabolite formation (Xia et al, 2009;Dong et al, 2011). As reported, erlotinib and panaxytriol, an active component in Shenmai injection (Zeng et al, 2013), both showed significant activation on MDZ 19-hydroxylation, whereas the activation but not inhibition made it difficult for the in vivo extrapolation. Moreover, either glucuronidation of hydroxylmidazolam or direct glucuronidation of MDZ occurs in vitro and in vivo (Klieber et al, 2008;Hyland et al, 2009;Seo et al, 2010).…”
Section: Discussionmentioning
confidence: 83%
“…In our previous study, panaxytriol showed differential effect on the metabolic pathways of MDZ, significantly inscreasing MDZ 1′-hydroxylation but inhibiting MDZ 4-hydroxylation. 11,12) This results revealed that PXT had the potential to inhibit or activate the CYP3A4 enzyme activity. Therefore, it is necessary to further study the impact mechanism of PXT on CYP3A4 enzyme and possible interaction with other clinical drugs.…”
mentioning
confidence: 79%
“…Shenmai injection, an injection made of Renshen (Panax ginseng) and Maidong (Ophiopogon japonicus), is commonly used to treat atherosclerotic coronary heart disease and viral myocarditis (20). Currently, it has been also widely applied in clinical practice as an organ protector (21).…”
Section: Discussionmentioning
confidence: 99%
“…Generally, Shenmai injection is considered effective and safe for clinical application. However, it was reported that Shenmai injection could inhibit the activities of hepatic CYP3A1/2 and CYP2C6 (25) and differentially affect CYP3A4-mediated 1'-hydroxylation and 4-hydroxylation of midazolam (20), suggesting potential HDIs could occur when it is co-used with other therapeutic drugs. Our previous study screened the ethanol extracts of 28 commonly used herb medicines and 34 bioactive components from these herb medicines for their capability to activate the PXR-CYP3A4 pathway.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation